Clinical Research


Temporomandibular Joint Arthritis (TMJ)

Rheumatology at Children's of Alabama is a worldwide leader in the diagnosis and treatment of TMJ arthritis in children with JIA.

Primer on TMJ Arthritis in Children with JIA


Macrophage Activation Syndrome (MAS)

MAS is a frequently fatal complication of certain rheumatic disorders, and Pediatric Rheumatology at UAB/Children's of Alabama is at the forefront for developing diagnostic criteria for and treatment of MAS in children.


Optimal Treatment for Juvenile Idiopathic Arthritis (JIA)

A grant to develop the first ever treatment guidelines for JIA was awarded to the UAB Division of Pediatric Rheumatology. The guidelines were published in 2010.


Treatment of Other Pediatric Rheumatic Diseases

Uncommon diseases often require innovative ideas in order to develop novel effective therapies. Pediatric Rheumatology at Children’s of Alabama takes a reasoned but aggressive approach to keep disease activity in check while minimizing toxicity from therapy.